Indiangoods.shop – FDA Warning Letter, Mar 1, 2026

On June 17, 2026, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Indiangoods.shop, an India-based company located in Hyderabad, following a regulatory review of its website in May 2026. The agency determined that the company is marketing several products—specifically Moon Herbal Josh Awar Khas, Kapiva Him Foods Testo Capsules, and Patanjali Youvan Gold Plus Capsule—as unapproved new drugs. These products are being promoted with claims to treat medical conditions, such as physical and sexual weakness, or to affect the body"s structure and function, such as increasing testosterone levels and libido. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), any product intended for such uses must be evaluated for safety and effectiveness and receive FDA approval before being introduced into interstate commerce. Because these products lack such approval, their sale violates federal law. The FDA has directed Indiangoods.shop to immediately correct these violations and investigate the root causes to prevent future issues. The company must provide a written response within fifteen business days detailing the specific corrective actions taken and providing supporting documentation. Failure to address these concerns adequately could lead to legal consequences, such as product seizures or injunctions.